In AML, the up-regulation of PD1 was reported in T-effector cells and in Tregs [106]; it is hypothesized that PD1 overexpression on CD8+ T-cells may account for CTL dysfunction and immune suppression during AML progression [124]. Here, CD8A is linked to acute myeloid leukemia.